Skip to content

Clinical trials

Completed Phase 2 Carcinoma, Ductal, Breast trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ductal, Breast Phase: Phase 2 Status: Completed Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20071
20081
20102
20131
20172
20191

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ARCAGY/ GINECO GROUP1
Assistance Publique - Hôpitaux de Paris1
Avelas Biosciences, Inc.1
City of Hope Medical Center1
GBG Forschungs GmbH1
Institut du Cancer de Montpellier - Val d'Aurelle1
Novartis Pharmaceuticals1
Radiation Therapy Oncology Group1
RenJi Hospital1
Rutgers, The State University of New Jersey1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ductal, Breast11
Breast Neoplasms7
Carcinoma, Lobular5
Inflammatory Breast Neoplasms5
Carcinoma, Intraductal, Noninfiltrating2
Adenocarcinoma1
Breast Carcinoma In Situ1
Breast Neoplasms, Male1
Brenner Tumor1
Carcinoma, Adenoid Cystic1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.